This week's news included managing infants with RSV, how COVID-19 surveillance has evolved, and looking at changing criteria for initial and sustained response to antibiotic treatment for C diff.
In early in vitro testing, a bacterial cellulose dressing loaded with bacteriophages reduced S aureus and P aeruginosa biofilms, and optimized versions reached 70% to 90% reductions.
PAHO revoked the US measles elimination status this week. Nina Masters, PhD, MPH, offers commentary on the factors leading to it including vaccine hesitancy as well as unintended consequences such as the outbreak-driven spikes in measles titer testing among adults over 50.
Ryan Shields, PharmD, MS, explains how rapid diagnostics, aggressive β-lactam dosing in CRRT, and cefepime-zidebactam fit within the IDSA 2026 guidance on antimicrobial-resistant Gram-negative infections.
The World Health Organization (WHO) confirmed 2 sporadic, camel-linked MERS-CoV infections with both patients recovered and no secondary transmission among 99 traced contacts.
The EMA issued a positive opinion for a 3-month dapivirine vaginal ring for HIV prevention in women and girls aged 16 and older, cutting annual product costs by nearly 60%.
Cefazolin evidenced non-inferiority and probable superiority, as well as greater safety compared to antistaphylococcal penicillins for methicillin-susceptible S aureus bacteremia, in meta-analysis of direct comparison trials.